Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2012

Open Access 01-12-2012 | Research article

QTc interval prolongation in HIV-infected patients: a case–control study by 24-hour Holter ECG recording

Authors: Alessandra Fiorentini, Nicola Petrosillo, Angelo Di Stefano, Stefania Cicalini, Laura Borgognoni, Evangelo Boumis, Luigi Tubani, Pierangelo Chinello

Published in: BMC Cardiovascular Disorders | Issue 1/2012

Login to get access

Abstract

Background

Aim of the study was to assess QTc interval by a 24-hour ECG recording in a group of HIV-infected individuals with a basal prolonged QTc. The risk factors associated with QTc prolongation and the indices of cardiovascular autonomic control were also evaluated.

Methods

A case–control study was performed using as cases 32 HIV-infected patients with prolonged (>440 msec) QTc interval as assessed by Holter ECG, and as controls 64 HIV-infected subjects with normal QTc interval. Autonomic function was evaluated by heart rate variability analysis during 24-hour recording.

Results

Duration of HIV disease was significantly longer among cases than among controls (p=0.04). Waist/hip ratio was also higher among cases than among controls (p=0.05). Frequency domain analysis showed the absence of physiologic decrease of low frequency (LF) in the night period in both cases and controls. The LF night in cases showed a statistically significant reduction when compared with controls (p=0.007).

Conclusions

In our study group, QTc interval prolongation was associated with a longer duration of HIV infection and with a greater waist/hip ratio. HIV patients with QTc interval prolongation and with a longer duration of HIV infection were more likely to have an impairment of parasympathetic and sympathetic cardiac component.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kocheril AG, Bokhari SAJ, Batsford WP, Sinusas AJ: Long QTc and torsades de pointes in human immunodeficiency virus disease. PACE. 1997, 20 (11): 2810-2816. 10.1111/j.1540-8159.1997.tb05439.x.CrossRefPubMed Kocheril AG, Bokhari SAJ, Batsford WP, Sinusas AJ: Long QTc and torsades de pointes in human immunodeficiency virus disease. PACE. 1997, 20 (11): 2810-2816. 10.1111/j.1540-8159.1997.tb05439.x.CrossRefPubMed
2.
go back to reference Sani MU, Okeahialam BN: QTc interval prolongation in patients with HIV and AIDS. J Natl Med Assoc. 2005, 97 (12): 1657-1661.PubMedPubMedCentral Sani MU, Okeahialam BN: QTc interval prolongation in patients with HIV and AIDS. J Natl Med Assoc. 2005, 97 (12): 1657-1661.PubMedPubMedCentral
3.
go back to reference Nordin C, Kohli A, Beca S, Zaharia V, Grant T, Leider J, Marantz P: Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients. J Electrocardiol. 2006, 39 (2): 199-205. 10.1016/j.jelectrocard.2005.09.001.CrossRefPubMed Nordin C, Kohli A, Beca S, Zaharia V, Grant T, Leider J, Marantz P: Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients. J Electrocardiol. 2006, 39 (2): 199-205. 10.1016/j.jelectrocard.2005.09.001.CrossRefPubMed
4.
go back to reference Reinsch N, Buhr C, Krings P, Kaelsch H, Neuhaus K, Wieneke H, Erbel R, Neumann T: Prevalence and risk factors of prolonged QTc interval in HIV-infected patients: results of the HIV-HEART study. HIV Clin Trials. 2009, 10 (4): 261-268. 10.1310/hct1004-261.CrossRefPubMed Reinsch N, Buhr C, Krings P, Kaelsch H, Neuhaus K, Wieneke H, Erbel R, Neumann T: Prevalence and risk factors of prolonged QTc interval in HIV-infected patients: results of the HIV-HEART study. HIV Clin Trials. 2009, 10 (4): 261-268. 10.1310/hct1004-261.CrossRefPubMed
5.
go back to reference Eisenhauer MD, Eliasson AH, Taylor AJ, Coyne PE, Wortham DC: Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients. Chest. 1994, 105 (2): 389-395. 10.1378/chest.105.2.389.CrossRefPubMed Eisenhauer MD, Eliasson AH, Taylor AJ, Coyne PE, Wortham DC: Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients. Chest. 1994, 105 (2): 389-395. 10.1378/chest.105.2.389.CrossRefPubMed
6.
go back to reference von Seidlein L, Jaffar S, Greenwood B: Prolongation of QTc interval in African children treated for falciparum malaria. Am J Trop Med Hyg. 1997, 56 (5): 494-497. von Seidlein L, Jaffar S, Greenwood B: Prolongation of QTc interval in African children treated for falciparum malaria. Am J Trop Med Hyg. 1997, 56 (5): 494-497.
7.
go back to reference Lopez JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T: QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazole. Am J Cardiol. 1987, 59 (4): 376-377. 10.1016/0002-9149(87)90824-1.CrossRefPubMed Lopez JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T: QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazole. Am J Cardiol. 1987, 59 (4): 376-377. 10.1016/0002-9149(87)90824-1.CrossRefPubMed
8.
go back to reference Gil M, Sala M, Anguera I, Chapinal O, Cervantes M, Guma JR, Segura F: QT prolongation and torsades de pointes in patients infected with human immunodeficiency virus and treated with methadone. Am J Cardiol. 2003, 92 (8): 995-997. 10.1016/S0002-9149(03)00906-8.CrossRefPubMed Gil M, Sala M, Anguera I, Chapinal O, Cervantes M, Guma JR, Segura F: QT prolongation and torsades de pointes in patients infected with human immunodeficiency virus and treated with methadone. Am J Cardiol. 2003, 92 (8): 995-997. 10.1016/S0002-9149(03)00906-8.CrossRefPubMed
9.
go back to reference Vallejo Camazon N, Rodriguez Pardo D, Sanchez Hidalgo A, Tornos Mas MP, Ribera E, Soler Soler J: Ventricular tachycardia and long QT associated with clarithromycin administration in a patient with HIV infection. Rev Esp Cardiol. 2002, 55 (8): 878-881.CrossRefPubMed Vallejo Camazon N, Rodriguez Pardo D, Sanchez Hidalgo A, Tornos Mas MP, Ribera E, Soler Soler J: Ventricular tachycardia and long QT associated with clarithromycin administration in a patient with HIV infection. Rev Esp Cardiol. 2002, 55 (8): 878-881.CrossRefPubMed
10.
go back to reference Flanagan MC, Mitchell ES, Haigney MC: Ciprofloxacin-induced torsade de pointes. Int J Cardiol. 2006, 113 (2): 239-241. 10.1016/j.ijcard.2005.08.048.CrossRefPubMed Flanagan MC, Mitchell ES, Haigney MC: Ciprofloxacin-induced torsade de pointes. Int J Cardiol. 2006, 113 (2): 239-241. 10.1016/j.ijcard.2005.08.048.CrossRefPubMed
11.
go back to reference Prabhakar M, Krahn AD: Ciprofloxacin-induced acquired long QT syndrome. Heart Rhythm. 2004, 1 (5): 624-626. 10.1016/j.hrthm.2004.06.020.CrossRefPubMed Prabhakar M, Krahn AD: Ciprofloxacin-induced acquired long QT syndrome. Heart Rhythm. 2004, 1 (5): 624-626. 10.1016/j.hrthm.2004.06.020.CrossRefPubMed
12.
go back to reference Castillo R, Pedalino RP, El-Sherif N, Turitto G: Efavirenz-associated QT prolongation and Torsade de Pointes arrhythmia. Ann Pharmacother. 2002, 36 (6): 1006-1008.CrossRefPubMed Castillo R, Pedalino RP, El-Sherif N, Turitto G: Efavirenz-associated QT prolongation and Torsade de Pointes arrhythmia. Ann Pharmacother. 2002, 36 (6): 1006-1008.CrossRefPubMed
13.
go back to reference Anson BD, Weaver JG, Ackerman MJ, Akinsete O, Henry K, January CT, Badley AD: Blockade of HERG channels by HIV protease inhibitors. Lancet. 2005, 365 (9460): 682-686.CrossRefPubMed Anson BD, Weaver JG, Ackerman MJ, Akinsete O, Henry K, January CT, Badley AD: Blockade of HERG channels by HIV protease inhibitors. Lancet. 2005, 365 (9460): 682-686.CrossRefPubMed
14.
go back to reference Ly T, Ruiz ME: Prolonged QT interval and torsades de pointes associated with atazanavir therapy. Clin Infect Dis. 2007, 44 (6): e67-e68. 10.1086/511875.CrossRefPubMed Ly T, Ruiz ME: Prolonged QT interval and torsades de pointes associated with atazanavir therapy. Clin Infect Dis. 2007, 44 (6): e67-e68. 10.1086/511875.CrossRefPubMed
15.
go back to reference Villa A, Foresti V, Confalonieri F: Autonomic neuropathy and prolongation of QT interval in human immunodeficiency virus infection. Clin Auton Res. 1995, 5 (1): 48-52. 10.1007/BF01845498.CrossRefPubMed Villa A, Foresti V, Confalonieri F: Autonomic neuropathy and prolongation of QT interval in human immunodeficiency virus infection. Clin Auton Res. 1995, 5 (1): 48-52. 10.1007/BF01845498.CrossRefPubMed
16.
go back to reference Freeman R, Roberts MS, Friedman LS, Broadbridge C: Autonomic function and human immunodeficiency virus infection. Neurology. 1990, 40 (4): 575-580. 10.1212/WNL.40.4.575.CrossRefPubMed Freeman R, Roberts MS, Friedman LS, Broadbridge C: Autonomic function and human immunodeficiency virus infection. Neurology. 1990, 40 (4): 575-580. 10.1212/WNL.40.4.575.CrossRefPubMed
17.
go back to reference Lane RD, Zareba W, Reis HT, Peterson DR, Moss AJ: Changes in ventricular repolarization duration during typical daily emotion in patients with long QT syndrome. Psychosom Med. 2011, 73 (1): 98-105. 10.1097/PSY.0b013e318203310a.CrossRefPubMed Lane RD, Zareba W, Reis HT, Peterson DR, Moss AJ: Changes in ventricular repolarization duration during typical daily emotion in patients with long QT syndrome. Psychosom Med. 2011, 73 (1): 98-105. 10.1097/PSY.0b013e318203310a.CrossRefPubMed
18.
go back to reference Bonnemeier H, Wiegand UK, Braasch W, Brandes A, Richardt G, Potratz J: Circadian profile of QT interval and QT interval variability in 172 healthy volunteers. Pacing Clin Electrophysiol. 2003, 26 (1Pt2): 377-382.CrossRefPubMed Bonnemeier H, Wiegand UK, Braasch W, Brandes A, Richardt G, Potratz J: Circadian profile of QT interval and QT interval variability in 172 healthy volunteers. Pacing Clin Electrophysiol. 2003, 26 (1Pt2): 377-382.CrossRefPubMed
19.
go back to reference Piotrovsky V: Pharmacokinetic-pharmacodynamic modelling in the data analysis and interpretation of drug-induced QT/QTc prolongation. AAPS J. 2005, 7 (3): E609-E624. 10.1208/aapsj070363.CrossRefPubMedPubMedCentral Piotrovsky V: Pharmacokinetic-pharmacodynamic modelling in the data analysis and interpretation of drug-induced QT/QTc prolongation. AAPS J. 2005, 7 (3): E609-E624. 10.1208/aapsj070363.CrossRefPubMedPubMedCentral
20.
go back to reference Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J: QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation. 1991, 84 (4): 1516-1523. 10.1161/01.CIR.84.4.1516.CrossRefPubMed Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J: QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation. 1991, 84 (4): 1516-1523. 10.1161/01.CIR.84.4.1516.CrossRefPubMed
21.
go back to reference Moss AJ: Measurement of the QT interval and the risk associated with QTc in interval prolongation: a review. Am J Cardiol. 1993, 72 (6): 23B-25B. 10.1016/0002-9149(93)90036-C.CrossRefPubMed Moss AJ: Measurement of the QT interval and the risk associated with QTc in interval prolongation: a review. Am J Cardiol. 1993, 72 (6): 23B-25B. 10.1016/0002-9149(93)90036-C.CrossRefPubMed
22.
go back to reference The Expert Panel: Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). final report. Circulation. 2002, 106 (25): 3143-3421. The Expert Panel: Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). final report. Circulation. 2002, 106 (25): 3143-3421.
23.
24.
go back to reference Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996, 93 (5): 1043-1065. 10.1161/01.CIR.93.5.1043.CrossRef Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996, 93 (5): 1043-1065. 10.1161/01.CIR.93.5.1043.CrossRef
25.
go back to reference Chinello P, Lisena FP, Angeletti C, Boumis E, Papetti F, Petrosillo N: Role of antiretroviral treatment in prolonging QTc interval in HIV-positive patients. J Infect. 2007, 54 (6): 597-602. 10.1016/j.jinf.2006.11.001.CrossRefPubMed Chinello P, Lisena FP, Angeletti C, Boumis E, Papetti F, Petrosillo N: Role of antiretroviral treatment in prolonging QTc interval in HIV-positive patients. J Infect. 2007, 54 (6): 597-602. 10.1016/j.jinf.2006.11.001.CrossRefPubMed
26.
go back to reference Benchimol-Barbosa PR: Circadian cardiac autonomic function in perinatally HIV-infected preschool children. Braz J Med Biol Res. 2009, 42 (8): 722-730. 10.1590/S0100-879X2009000800006.CrossRefPubMed Benchimol-Barbosa PR: Circadian cardiac autonomic function in perinatally HIV-infected preschool children. Braz J Med Biol Res. 2009, 42 (8): 722-730. 10.1590/S0100-879X2009000800006.CrossRefPubMed
27.
go back to reference Charbit B, Rosier A, Bollens D, Boccara F, Boelle PY, Koubaa A, Girard PM, Funck-Brentano C: Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients: a cross-sectional study. Br J Clin Pharmacol. 2009, 67 (1): 76-82. 10.1111/j.1365-2125.2008.03332.x.CrossRefPubMedPubMedCentral Charbit B, Rosier A, Bollens D, Boccara F, Boelle PY, Koubaa A, Girard PM, Funck-Brentano C: Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients: a cross-sectional study. Br J Clin Pharmacol. 2009, 67 (1): 76-82. 10.1111/j.1365-2125.2008.03332.x.CrossRefPubMedPubMedCentral
28.
go back to reference Becker K, Gorlach I, Frieling T, Haussinger D: Characterization and natural course of cardiac autonomic nervous dysfunction in HIV-infected patients. AIDS. 1997, 11 (6): 751-757. 10.1097/00002030-199706000-00008.CrossRefPubMed Becker K, Gorlach I, Frieling T, Haussinger D: Characterization and natural course of cardiac autonomic nervous dysfunction in HIV-infected patients. AIDS. 1997, 11 (6): 751-757. 10.1097/00002030-199706000-00008.CrossRefPubMed
29.
go back to reference Mittal CM, Wig N, Mishra S, Deepak KK: Heart rate variability in human immunodeficiency virus-positive individuals. Int J Cardiol. 2004, 94 (1): 1-6. 10.1016/j.ijcard.2003.02.002.CrossRefPubMed Mittal CM, Wig N, Mishra S, Deepak KK: Heart rate variability in human immunodeficiency virus-positive individuals. Int J Cardiol. 2004, 94 (1): 1-6. 10.1016/j.ijcard.2003.02.002.CrossRefPubMed
30.
go back to reference Fliers E, Sauerwein HP, Romijn JA, Reiss P, van der Valk M, Kalsbeek A, Kreier F, Buijs RM: HIV-associated adipose redistribution syndrome as a selective autonomic neuropathy. Lancet. 2003, 362 (9397): 1758-1760. 10.1016/S0140-6736(03)14858-1.CrossRefPubMed Fliers E, Sauerwein HP, Romijn JA, Reiss P, van der Valk M, Kalsbeek A, Kreier F, Buijs RM: HIV-associated adipose redistribution syndrome as a selective autonomic neuropathy. Lancet. 2003, 362 (9397): 1758-1760. 10.1016/S0140-6736(03)14858-1.CrossRefPubMed
31.
go back to reference Szabados E, Fisher GM, Toth K, Csete B, Nemeti B, Trombitas K, Habon T, Endrei D, Sumegi B: Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Radic Biol Med. 1999, 26 (3–4): 309-317.CrossRefPubMed Szabados E, Fisher GM, Toth K, Csete B, Nemeti B, Trombitas K, Habon T, Endrei D, Sumegi B: Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Radic Biol Med. 1999, 26 (3–4): 309-317.CrossRefPubMed
32.
go back to reference Williams ES, Thomas KL, Broderick S, Shaw LK, Velazquez EJ, Al-Khatib SM, Daubert JP: Race and gender variation in the QT interval and its association with mortality in patients with coronary artery disease: results from the Duke Databank for Cardiovascular Disease (DDCD). Am Heart J. 2012, 164 (3): 434-441. 10.1016/j.ahj.2012.05.024.CrossRefPubMed Williams ES, Thomas KL, Broderick S, Shaw LK, Velazquez EJ, Al-Khatib SM, Daubert JP: Race and gender variation in the QT interval and its association with mortality in patients with coronary artery disease: results from the Duke Databank for Cardiovascular Disease (DDCD). Am Heart J. 2012, 164 (3): 434-441. 10.1016/j.ahj.2012.05.024.CrossRefPubMed
Metadata
Title
QTc interval prolongation in HIV-infected patients: a case–control study by 24-hour Holter ECG recording
Authors
Alessandra Fiorentini
Nicola Petrosillo
Angelo Di Stefano
Stefania Cicalini
Laura Borgognoni
Evangelo Boumis
Luigi Tubani
Pierangelo Chinello
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2012
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-12-124

Other articles of this Issue 1/2012

BMC Cardiovascular Disorders 1/2012 Go to the issue